Assisted Reproduction

We analyse the patient’s reproductive capacity so that the results can help in the process of deciding which fertility treatment a couple should follow.

We look for the sperm chromosomal abnormalities potentially responsible for implantation failures or recurrent miscarriages.

We use ARTs to help you rule out the slightest potential risk of transmitting HTLV to the baby so that no cycle is delayed.

We help you determine if the patient has a high % of DNA fragmentation in their semen sample, whether by SSB (iatrogenic cause) or DSB (idiopathic cause), that cause IF (implantation failure) or RM (recurrent miscarriages) so that the appropriate measures can be taken to choose the correct ART method.

In a single test, we combine the genetic variants associated with recurrent miscarriages and venous thromboembolism in pregnancy, so that we can guide the clinic in the implementation of the appropriate preventive measures.

We design specific profiles for each clinic, which enables us to select the most appropriate tests to obtain the best information to help the clinic elucidate the reason for the patient’s recurrent miscarriages at the lowest possible cost and as quickly as possible.

We study the specific coagulation factors that have an impact on the implantation of the embryo in the endometrium.

We can perform a molecular analysis of the vaginal and/or endometrial microbiota which enables us to detect any changes associated with a higher risk of embryo implantation failure in the endometrium, simultaneously analysing both the bacterial balance and the presence/absence of pathogens.

We make it so simple and inexpensive to determine the AMH for identifying the ovarian reserve that clinics can routinely offer it to all patients.

We issue a quick and complete AP study that enables detection of any anomalies that can have a negative impact on potential ARTs, so that we can expand the necessary tests to anticipate your needs.

We collaborate closely and fully with the clinic so that, in those cases where the medical centre obtains foetal remains, we can help elucidate the possible genetic causes to help prevent the same outcome in a future pregnancy.

Genetic study on specific reproductive chromosomal variants that constitute a genetic risk factor.

Study of carriers of X-linked recessive or monogenic diseases in couples, recipients or donors through NGS sequencing.

We install a proprietary IT platform so that the clinic itself can perform this process on-site and in real time, by means of either:

• preconGEN vs preconGEN
• preconGEN vs another genetic screening test

We have a wide range of profiles designed to rule out all the risk situations requested by your patients.

Several studies seem to indicate that specific combinations of the maternal KIR genotype and the HLAC genotype of both parents could be responsible for poor placentation of the embryo.

For all cases in which the matching is inconclusive, we analyse all the mutations that are required in order to continue with the matching.

We help clinics to fulfil the legal requirements in a simple and economical way, storing the samples required by law until two years after birth or for the period stipulated by the clinic for security purposes or R&D studies.

Our aim is to detect and genotype 16 HPV types, two low risk types (HPV 6 and 11) and 14 high oncogenic risk types (HPV 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66 and 68).

Our aim is to rule out the slightest potential risk of Zika transmission to the baby, using ARTs as soon as possible so that no cycle is delayed.

We design specific profiles for each clinic to help select the best donors with the minimum number of tests.

We design specific profiles for each clinic to help select the best donors with the minimum number of tests.

We adapted to the new SIRHA (Spanish Assisted Human Reproduction Information System) requirements by designing special logistics, based on the use of rapid PCR techniques such as NAATs, to optimize the 72 hours needed to issue the result, thereby reducing turnaround times at the lowest possible cost.